Connection

Maria De Santis to Aged, 80 and over

Back to Details
This is a "connection" page, showing publications Maria De Santis has written about Aged, 80 and over.
Maria De Santis
Connection Strength
0.021
Aged, 80 and over
  1. SWITCH II: Phase III randomized, sequential, open-label study to evaluate the efficacy and safety of sorafenib-pazopanib versus pazopanib-sorafenib in the treatment of advanced or metastatic renal cell carcinoma (AUO AN 33/11). Eur J Cancer. 2019 01; 107:37-45.
    View in: PubMed
    Score: 0.006
  2. Impact of Primary Tumor Location on Survival from the European Organization for the Research and Treatment of Cancer Advanced Urothelial Cancer Studies. J Urol. 2018 05; 199(5):1149-1157.
    View in: PubMed
    Score: 0.005
  3. Detection of anti-mitochondrial antibodies by immunoprecipitation in patients with systemic sclerosis. J Immunol Methods. 2018 01; 452:1-5.
    View in: PubMed
    Score: 0.005
  4. The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review. Eur Urol. 2017 07; 72(1):84-109.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.